The weed wire

The company has cut back on operating expenses in an effort to weather the current economic storm

Company gears up for in-house cannabis 2.0 launch in provinces, territories

Shift in public opinion supports push for federal legalization, says NORML director

Aphria and Emblem entered supply deal in 2018 for 175,000 kilograms of cannabis. The following year Aleafia Health acquired Emblem and the deal was terminated

Cross-border acquisition deal amended due to current 'volatile financial market conditions'

Company credits current success to aggressive expansion during Covid-19

Peer-reviewed study associated cannabis use with long-term reduction of migraine frequency, less related disability and lower anti-migraine intake

Joint venture between Village Farms and Emerald Health now ships to 70% of Canada's population

Allied Corp partners with MGC Pharmaceuticals to further therapy options for veterans and first responders

Company uses low-cost outdoor production for medical vape products and plans for adult-use expansion

The 30 mL, 10 mg drinkable is marketed as the first 'true alternative' to smoking weed

Canopy CEO predicts US federal legalization in 2022, which would finalize weed giant's acquisition of Acreage

Unofficial guidance for the first quarter 2020 shows continued revenue growth

But the Canadian weed retailer was still unprofitable in Q1 as expenses remained high

Company says Sunens facility will support production of its industry-leading cannabis 2.0 products

The new research refutes findings from previous studies that suggested a correlation

The 420,000 square foot facility can be scaled up to 2.2M square feet of cultivation space

Company says it planted 18,000 clones outdoors, predicts Q1 revenue will jump to $12 million

Controversial retail deal decreases by three California stores and US$12.5 million

Canopy-funded initiative aims to fill knowledge gap about weed among medical professionals

Deal to import 3,000 kilograms of medical weed to Canndoc has option to double

Revenues grew by just 4% in the last quarter, but company projects 90% growth over the current period

Report shows Aurora leading dried flower sales in Canada's biggest province

Prime Minister Netanyahu says Canada's legal market will provide model for his country's system

Company says the deal is a crucial step in bringing its cancer pain treatment to market

The company says it's already completing orders in BC and Saskatchewan

Company pivots from extraction to infused food and drink markets

Bulk options help reduce packaging, says company

Las Vegas company says adding 24-hour delivery helped relieve some pressure from pandemic-related tourism collapse

The company says it has filed 13 patents in the US and Canada for its proprietary cannabis tablets

Company says infused candies and vapes made up 90% of first-quarter Canadian weed sales

The accordion loan can expand up to another $10 million

Outdoor producer updates ALEF trading symbol to AH

Company's Vaughan production facility remains in limbo

High Parks Gardens facility shutdown will save parent company $7.5 million annually while losing 120 workers

TerrAscend's strategy of focusing on US markets continue to pay off

If it works on dogs then it will likely work on humans too, researchers say

Studies showed CBN formulations reduced interocular pressure and protected retinal cells in the eye

Company books $660K in Canadian weed sales with a net loss of $73.4 million in Q1

Multi-state operator says Ohio has over 100,000 registered patients and lacks competition